A systematic review of the safety information contained within the Summaries of Product Characteristics of medications licensed in the United Kingdom for Attention Deficit Hyperactivity Disorder. how does the safety prescribing advice compare with national guidance?

BACKGROUND: The safety of paediatric medications is paramount and contraindications provide clear pragmatic advice. Further advice may be accessed through Summaries of Product Characteristics (SPCs) and relevant national guidelines. The SPC can be considered the ultimate independent guideline and is...

Descripción completa

Detalles Bibliográficos
Autores principales: Savill, Nicola, Bushe, Chris J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317854/
https://www.ncbi.nlm.nih.gov/pubmed/22234242
http://dx.doi.org/10.1186/1753-2000-6-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317854/
https://www.ncbi.nlm.nih.gov/pubmed/22234242
http://dx.doi.org/10.1186/1753-2000-6-2

Ejemplares similares